Dongjie Ma

680 total citations
43 papers, 434 citations indexed

About

Dongjie Ma is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Dongjie Ma has authored 43 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Dongjie Ma's work include Lung Cancer Diagnosis and Treatment (10 papers), Cancer-related molecular mechanisms research (8 papers) and Circular RNAs in diseases (7 papers). Dongjie Ma is often cited by papers focused on Lung Cancer Diagnosis and Treatment (10 papers), Cancer-related molecular mechanisms research (8 papers) and Circular RNAs in diseases (7 papers). Dongjie Ma collaborates with scholars based in China, Chile and Germany. Dongjie Ma's co-authors include Shanqing Li, Yingzhi Qin, Xiaoyun Zhou, Yeye Chen, Hongsheng Liu, Cheng Huang, Zhijun Han, Feng Guo, Jia He and Hongsheng Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Energy and Gene.

In The Last Decade

Dongjie Ma

42 papers receiving 427 citations

Peers

Dongjie Ma
Comparison fields: 5 of 80
  • Molecular Biology 202
  • Cancer Research 157
  • Pulmonary and Respiratory Medicine 117
  • Surgery 60
  • Oncology 53
Replace Qing Xue with:
Qing Xue China
Hongbin Gao China
Qianqian Yang China
Ruihao Li China
Minji Jung South Korea
Simona Inghilleri Italy
Junshu Li China
Guozhi Zhao China
Jianli Hu China
Qing Xue China View profile →
Citations per field, relative to Dongjie Ma
Dongjie Ma · 1×
Citations per year, relative to Dongjie Ma
Dongjie Ma · 1×

Countries citing papers authored by Dongjie Ma

Since Specialization
Citations

This map shows the geographic impact of Dongjie Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongjie Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongjie Ma more than expected).

Fields of papers citing papers by Dongjie Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongjie Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongjie Ma. The network helps show where Dongjie Ma may publish in the future.

Co-authorship network of co-authors of Dongjie Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Dongjie Ma. A scholar is included among the top collaborators of Dongjie Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongjie Ma. Dongjie Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 3
2 6
3 2
4 5
5 1
6 15
7 3
8 15
9 7
10 8
11
Circ_0007142/miR-186/FOXK1 axis promoted lung adenocarcinoma progression.
20
12 15
13 0
14 27
15 1
16 3
17 8
18 11
19 2
20 8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026